Trials / Completed
CompletedNCT04453215
Laser Therapy for Patients With Systemic Lupus Erythematosus
The Effect of Dental Laser Therapy for Patients With Systemic Lupus Erythematosus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 91 (actual)
- Sponsor
- Dr. Merve Benli · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease that has detrimental effects on connective tissue and other organs. The musculoskeletal system is one of the most affected systems in this group of patients including the temporomandibular joint. The most common symptoms when muscle involvement in SLE are muscle atrophy decreased muscle strength and myopathy. SLE activity and long-term corticosteroid use are thought to be responsible for these symptoms, thus, SLE patients are accepted to be at higher risk for temporomandibular joint disorders (TMD). Low-level laser therapy(LLLT) is frequently used in the treatment of TMD due to its pain relief and anti-inflammatory effect. Thus, in this study, LLLT has been used to evaluate this treatment modality on the chewing function and pain values of SLE patients with myogenic TMD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GaAlAs semiconductor diode laser device | low-level laser therapy |
Timeline
- Start date
- 2019-01-12
- Primary completion
- 2019-12-23
- Completion
- 2020-03-15
- First posted
- 2020-07-01
- Last updated
- 2021-11-10
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04453215. Inclusion in this directory is not an endorsement.